Sie suchten nach: divertikulitis (Dänisch - Englisch)

divertikulitis
diverticulitis

divertikulitis pancreatitis
diverticulitis pancreatitis

betændelse i tyktarmen (divertikulitis).
diverticulitis (inflammation of the large intestine).

mavesmerter, tarmobstruktion, ileus/subileus, divertikulitis og tarmperforation.
abdominal pain, intestinal obstruction, ileus/subileus, diverticulitis, intestinal perforation

rapporterede, alvorlige infektioner omfattede cellulitis, divertikulitis, osteomyelitis, virusinfektioner, gastroenteritis, lungebetændelse og urinvejsinfektioner.
in the controlled and non-controlled portions of psoriasis clinical studies, the rate of infection was 1.24 per patient-year of follow-up in ustekinumab-treated patients, and the incidence of serious infections was 0.01 per patient-year of follow-up in ustekinumab-treated patients (24 serious infections in 2,251 patient-years of follow-up) and serious infections reported included cellulitis, diverticulitis, osteomyelitis, viral infections, gastroenteritis, pneumonia, and urinary tract infections.

i nogle af disse tilfælde var intraabdominal inflammation allerede erkendt, enten fra mavesår, tumornekrose, divertikulitis eller kemoterapiassocieret kolitis.
in some cases underlying intra-abdominal inflammation was present, either from gastric ulcer disease, tumour necrosis, diverticulitis, or chemotherapy-associated colitis.

andre alvorlige bivirkninger • blødning fra endetarmen (rektum). • betændelse i tyktarmen (divertikulitis).
other serious side effects • bleeding from the back passage (rectum) • diverticulitis (inflammation of the large intestine).

de alvorlige infektioner, der blev rapporteret hos mindst én af de patienter, der fik behandling med abatacept (0, 05% af patienterne) omfattede følgende: pneumoni; bronkitis; cellulitis; akut pyelonefritis; urinvejsinfektion; divertikulitis, intestinal absces; lokaliseret infektion; hudabsces; muskelskeletale infektioner; sepsis; empyema; hepatitis e og tuberkulose (se pkt.4. 4) .
serious infections reported in at least one patient treated with abatacept (0.05% of patients) included the following: pneumonia; bronchitis; cellulitis; acute pyelonephritis; urinary tract infection; diverticulitis, intestinal abscess; localised infection; skin abscess; musculoskeletal infections; sepsis; empyema; hepatitis e; and tuberculosis (see section 4.4) .